ArticleBMC infectious diseases2025
Serological and molecular detection of hepatitis C virus in Amran governorate, Yemen.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Epidemiological trend and clinical features of diphtheria in Hajjah Governorate, Yemen: a seven-years retrospective analysis (2018-2024).BMC infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatitis C virus (HCV) is a blood-borne virus that causes acute or chronic hepatitis, depending on its severity, and its development leads to cirrhosis or hepatocellular carcinoma. This study aimed to detect HCV using the serological and molecular techniques among blood donors and clinical visitors in Amran governorate, Yemen.
methodsA total of 800 blood specimens were collected from blood donors (500 specimens) and clinical visitors (300 specimens). Blood specimens were screened for HCV using an immunochromatographic technique (ICT) and the enzyme-linked immunosorbent assay (ELISA), and the final positive cases for HCV were confirmed by nested polymerase chain reaction (nPCR).
resultsOut of 800 specimens, only 21 (2.6%) were reported as positive for HCV by molecular analysis. According to diagnostic techniques, 18 (2.3%), 22 (2.7%), and 21 (2.6%), respectively, of specimens were reported as positive for HCV by ICT, ELISA, and PCR techniques. Moreover, a higher rate of HCV was found among participants aged 21-30 years (4.3%), females (2.5%), urban residents (2.7%), single individuals (3.1%), and uneducated individuals (6.1%). In addition, the proportion of HCV was significantly higher among participants with a family history of HCV infection (11.6%), previous surgery (30.8%), no blood transfusion (2.9%), prior cupping (9.1%), and perinatal injury (4.6%).
conclusionThis finding indicates that the prevalence rate of HCV infection in the study area is high. To protect the general public from the spread of HCV infection, it is essential to develop a public health approach including surveillance and monitoring, strengthening infrastructure, training healthcare workers in early detection and treatment of cases, and increasing public awareness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.